ThursdayFeb 25, 2021 2:45 pm

Study Discovers That Protein Imbalance May Cause Cataracts

Cataracts are a common eye disease, and while researchers have yet to fully understand how the disease works, plenty of research has been done on this ailment. Recently, a group of researchers at the Technical University of Munich (“TUM”) found that the composition of the protein solution was a factor in the disease. The researchers’ findings go against the field’s popular opinion. TUM’s chair of biotechnology Prof. Johannes Buchner explained that the cells in an eye lens are comprised of a protein solution that is highly concentrated and normally clear. However, he continued, a protein imbalance may cause the proteins to…

Continue Reading

ThursdayFeb 25, 2021 12:55 pm

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) Reports Its Plant-Based Biopesticide Has Positive Impact on Soil Health

Studies confirm natural active ingredient, which is in MustGrow’s biopesticide, has a positive impact on soil health Soil micro-organisms play crucial role in soil fertility, plant health MustGrow's safe, effective natural biopesticide is plant based, derived from the mustard seed's natural defense mechanism MustGrow Biologics (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) has released study findings that confirm that the active ingredient in its mustard plant-based technology actually has a positive impact on soil health (https://ibn.fm/AeMYp). The studies have found that an application of the natural ingredient Allyl Isothiocyanate (“AITC”) returns organic plant material to the soil and contributes to the environmental…

Continue Reading

WednesdayFeb 24, 2021 3:25 pm

Report Finds Vaccine Passports Feasible, But May Face Some Difficulties

A report released last week from a panel led by Prof. Chris Dye and Prof. Melinda Mills from the University of Oxford, states that while coronavirus vaccine passports are a feasible idea, there are a few challenges that need to be addressed before they could be developed. The report was published at the Royal Society. The report, which also gave a summary of these issues, stated that the primary concern was that any passport should disclose if its holder was protected from the coronavirus and would not be able to transmit the disease. Apart from this, passports would also be…

Continue Reading

WednesdayFeb 24, 2021 3:18 pm

United Medical Equipment Business Solutions Network Inc. Providing Solutions to Combat the Spread of COVID-19

UME is trusted supplier of FDA-approved antibody, antigen test kits United moved quickly to address growing needs created by COVID-19 Company dedicated to providing guidance to aging population, their families and medical staff supporting them United Medical Equipment Business Solutions Network is a company focused on the needs of aging patients and veteran communities as well as those impacted by the COVID-19 pandemic. United is a trusted supplier of FDA-approved antibody and antigen test kits, medical equipment and personal protective equipment (“PPE”). As the world attempts to control this pandemic, it is essential to quickly identify who is infected and…

Continue Reading

WednesdayFeb 24, 2021 1:34 pm

PlantX Life Inc.’s (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Collaboration with Farm Cup Coffee Designed to Boost Brand, Reach Customers and Inspire Lifestyles

PlantX to display and sell its indoor plants at Farm Cup Coffee’s highly attractive West Hollywood location The careful partnership aligns perfectly with PlantX’s commitment to supporting healthy lifestyles and community empowerment PlantX opens wide the potential of indoor plants, making it both easy and appealing to discover what the world of plants can provide As the digital face of the plant-based community, PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is taking another step to solidify its position as a one-stop shop for everything plant-based. The Company recently announced that has entered into a new collaboration with Farm Cup…

Continue Reading

WednesdayFeb 24, 2021 1:19 pm

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiaries Ink Significant Contract, Announce Sale of Media to Top Medical Centers

POAI subsidiary inks contract with significant pharmaceutical company TumorGenesis announces sale of media to research medical centers in New York City, Boston Potential market for 3D cancer cell culture media expected to reach $3.2 billion sales worldwide by 2027 Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that one of its wholly owned subsidiaries, Soluble Biotech, recently inked another contract with a large pharmaceutical company (https://ibn.fm/OpaJb). POAI also announced that TumorGenesis, one of its wholly owned subsidiaries, has sold media to two top research medical centers (https://ibn.fm/uXorQ). Soluble Biotech’s contract will…

Continue Reading

TuesdayFeb 23, 2021 12:15 pm

Researchers Document Small Window Within Which Stroke Recovery Is Highest

In a groundbreaking study, two teams of researchers — one based at the University of South Australia in Adelaide and another in London — have shown that stroke recovery peaks at approximately two weeks after the stroke and then gradually diminishes with the passage of time. The teams at Adelaide and London followed a total of 60 patients who had had a stroke. This follow-up lasted up to 12 months after the stroke. Dr. Brenton Hordacre, based at the University of South Australia in Adelaide and also the lead author of the study, explained that this multisite study was intended…

Continue Reading

MondayFeb 22, 2021 12:44 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Advances Rapid COVID Test System, Expands Psychedelic Medicine Programs

Life sciences industry accelerator XPhyto Therapeutics Corp. has developed a timeline for the approval and rollout of a rapid, portable COVID-19 test it expects to become available by April in Europe XPhyto’s Covid-ID Lab system is designed to help industries economically devastated by the pandemic to form strategies based on quick and accurate testing, particularly the travel industry The company intends to use its test tech partnership with Germany’s 3a-diagnostics GmbH to build additional bacteriological and viral testing products A separate subsidiary based in Alberta is developing psychedelic medicine programs The subsidiary recently announced it has added mescaline production to…

Continue Reading

MondayFeb 22, 2021 12:15 pm

Coronavirus Pandemic Exposes Biomedical Waste Disposal Challenge in India

The coronavirus pandemic has impacted various sectors, including the environment, economic, social and health industries. While the vaccine has given people hope, the absence of a strategy that will be used to dispose of any coronavirus-related biomedical waste remains a threat. The Central Pollution Control Board in India recently released data showing that between June and December 20202, the coronavirus-related biomedical waste that was generated measured an estimated 33,000 tons. Earlier in July, the board presented a report to the National Green Tribunal indicating that India generated 101 MT of coronavirus-related biomedical waste daily and an additional 609 metric tons…

Continue Reading

MondayFeb 22, 2021 11:56 am

Convertible Note Progress Brings Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Closer to Commercialization of New Surgical Tech

Imagin Medical Inc. announced that it has now raised $2.165 million of the recent its convertible note offering The closing of the latest funding tranche will support the company’s progress toward the commercialization of its revolutionary bladder cancer visualization technology once final FDA approval is granted With better viewing options, the technology is designed to make it easier for surgeons to detect the full parameters of bladder tumors and remove them more completely Bladder cancer is one of the most prevalent cancers in the United States, particularly in men The technological improvement of these surgical procedures can provide an attractive…

Continue Reading

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050